0JG5 Stock Overview
Bittium Oyj provides solutions for communications and connectivity, healthcare technology products and services, and biosignal measuring and monitoring in Finland, Germany, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0JG5 from our risk checks.
Bittium Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €6.06 |
| 52 Week High | €6.14 |
| 52 Week Low | €3.36 |
| Beta | 0.78 |
| 1 Month Change | 25.60% |
| 3 Month Change | 28.00% |
| 1 Year Change | 47.10% |
| 3 Year Change | -8.87% |
| 5 Year Change | -10.15% |
| Change since IPO | 267.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0JG5 | GB Software | GB Market | |
|---|---|---|---|
| 7D | 2.4% | 2.2% | 2.7% |
| 1Y | 47.1% | 31.3% | 0.3% |
Return vs Industry: 0JG5 exceeded the UK Software industry which returned 28% over the past year.
Return vs Market: 0JG5 exceeded the UK Market which returned -1.8% over the past year.
Price Volatility
| 0JG5 volatility | |
|---|---|
| 0JG5 Average Weekly Movement | n/a |
| Software Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0JG5's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0JG5's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 526 | Johan Westermarck | www.bittium.com |
Bittium Oyj provides solutions for communications and connectivity, healthcare technology products and services, and biosignal measuring and monitoring in Finland, Germany, and the United States. It offers medical technologies products and solutions, including holter, long-term cardiac, and cardiac event monitoring; mobile cardiac telemetry; tools for biosignal analysis; medical service platform solutions; home sleep apnea testing; EEG monitoring for ICU and ER; and neuroscientific research, as well as Bittium Faros, HolterPlus, MedicalSuite, cardiac navigator, ECG electrodes, Respiro, BrainStatus, and NeurOne. The company also provides engineering services, such as industrial IoT, radio unit, medical and healthcare, mobiles devices, and mobile satellite communications; and system and architecture design, electronics, mechanics, RF and antenna design, software development, product testing and verification, DevOps, and certified management systems, as well as cellular IoT solution.
Bittium Oyj Fundamentals Summary
| 0JG5 fundamental statistics | |
|---|---|
| Market cap | €211.50m |
| Earnings (TTM) | -€5.43m |
| Revenue (TTM) | €75.50m |
2.8x
P/S Ratio-38.9x
P/E RatioIs 0JG5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0JG5 income statement (TTM) | |
|---|---|
| Revenue | €75.50m |
| Cost of Revenue | €59.29m |
| Gross Profit | €16.21m |
| Other Expenses | €21.64m |
| Earnings | -€5.43m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 21.47% |
| Net Profit Margin | -7.19% |
| Debt/Equity Ratio | 18.6% |
How did 0JG5 perform over the long term?
See historical performance and comparison